February 2025; papers of the month

February 2025’s research review evaluates three critical clinical studies. A retrospective analysis of out-of-hospital status epilepticus indicates that adding ketamine to midazolam protocols may increase seizure cessation rates, though further randomized controlled trials are required to confirm efficacy. Regarding trauma management, the TraumOx2 trial demonstrates that restrictive oxygen strategies—aiming for 94% saturation—yield similar 30-day mortality and respiratory complication rates as liberal oxygen administration, supporting a more pragmatic, titrated approach. Finally, the HEMOTION trial examines transfusion thresholds in traumatic brain injury, revealing that a liberal hemoglobin threshold of 10 g/dL provides no significant neurological benefit at six months compared to a restrictive threshold of 7 g/dL. These findings collectively highlight the need for nuanced, evidence-based adjustments in emergency and critical care protocols rather than rigid adherence to traditional high-dose or high-threshold practices.